Drug Profile
Research programme: antibody-maytansinoid conjugates - Bayer HealthCare
Alternative Names: Mesothelin-ADCsLatest Information Update: 14 Feb 2024
Price :
$50
*
At a glance
- Originator Bayer HealthCare
- Class Antibodies; Drug conjugates; Immunoconjugates; Maytansinoids; Monoclonal antibodies
- Mechanism of Action Tubulin modulators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Solid tumours